Skip to main content
Top
Published in: Journal of Clinical Immunology 3/2017

01-04-2017 | Letter to Editor

Different Immunological Pathways Underlie the Immune Response to Pneumococcal Polysaccharides

Authors: Leen Moens, Capucine Picard, Mohammad Shahrooei, Greet Wuyts, Adrian Liston, Alain Fischer, Xavier Bossuyt

Published in: Journal of Clinical Immunology | Issue 3/2017

Login to get access

Excerpt

Measurement of the antibody response to Pneumovax®/Pneumo23®, a 23-valent pneumococcal polysaccharide vaccine, is an established method to evaluate B cell function. Such evaluation typically involves measurement of pre- and post-vaccination serotype-specific antibody levels. …
Literature
1.
go back to reference Harding CV, Roof RW, Allen PM, Unanue ER. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1991;88:2740–4.CrossRefPubMedPubMedCentral Harding CV, Roof RW, Allen PM, Unanue ER. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1991;88:2740–4.CrossRefPubMedPubMedCentral
2.
go back to reference Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell. 1991;66:1051–66.CrossRefPubMed Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell. 1991;66:1051–66.CrossRefPubMed
3.
go back to reference Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol. 2005;7:1398–403.CrossRefPubMed Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol. 2005;7:1398–403.CrossRefPubMed
4.
go back to reference Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 2011; 118:5108–5118. Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 2011; 118:5108–5118.
5.
go back to reference Jeurissen A, Wuyts G, Kasran A, Ramdien-Murli S, Blanckaert N, Boon L, Ceuppens JL, Bossuyt X. The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40 ligand interaction. Eur J Immunol. 2004;34:850–8.CrossRefPubMed Jeurissen A, Wuyts G, Kasran A, Ramdien-Murli S, Blanckaert N, Boon L, Ceuppens JL, Bossuyt X. The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40 ligand interaction. Eur J Immunol. 2004;34:850–8.CrossRefPubMed
Metadata
Title
Different Immunological Pathways Underlie the Immune Response to Pneumococcal Polysaccharides
Authors
Leen Moens
Capucine Picard
Mohammad Shahrooei
Greet Wuyts
Adrian Liston
Alain Fischer
Xavier Bossuyt
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 3/2017
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0380-z

Other articles of this Issue 3/2017

Journal of Clinical Immunology 3/2017 Go to the issue